Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03573128 · ClinicalTrials.gov registry record · NA
Development and Pilot Testing of the Students With Autism Accessing General Education (SAAGE) Model
A NA study, sponsored by University of Rochester.
- Completed
- Registry status
- NA
- Development phase
- 72
- Enrollment target
NCT03573128: Completed NA study, sponsored by University of Rochester.
NCT03573128 is a NA study that has completed, run by University of Rochester. The registered enrollment target is 72 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (95% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03573128, a NA study, has completed, sponsored by University of Rochester.
- COMPLETED
- Registry status
- NA
- Development phase
- 72 participants
- Enrollment target
Study Summary
Study personnel will use evidence based behavioral skills training procedures to coach educators to implement modules designed to increase the quality of educational services and access to inclusive settings in elementary school for students with Autism Spectrum Disorder.
Primary Outcome
The Developmental Disability-Clinical Global Assessment Scale ranges from 1-100 with 100 indicating superior functioning. It assesses student function in a classroom setting.
Interventions
- BEHAVIORAL Students with Autism Accessing General Education
- OTHER Enhanced Services As Usual
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 72 participants |
| Start Date | 2017-08-01 |
| Est. Completion | 2018-08-28 |
| Phase | NA |
What the finished NCT03573128 record still lists
NCT03573128 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 72 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (95% lower).
The record links to 0 conditions, and to 2 interventions - of which Students with Autism Accessing General Education is the first listed.
NCT03573128 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03573128 about?
NCT03573128 is a clinical study titled "Development and Pilot Testing of the Students With Autism Accessing General Education (SAAGE) Model". Study personnel will use evidence based behavioral skills training procedures to coach educators to implement modules designed to increase the quality of educational services and access to inclusive settings in elementary school for students with Autism Spectrum Disorder.
What is the current status of trial NCT03573128?
This trial is currently completed. It is a NA study. The enrollment target is 72 participants. The study started on 2017-08-01. Estimated completion is 2018-08-28.
What interventions are being tested in trial NCT03573128?
The interventions under investigation include: Students with Autism Accessing General Education (BEHAVIORAL), Enhanced Services As Usual (OTHER).
Who is sponsoring clinical trial NCT03573128?
This trial is sponsored by University of Rochester, which has 636 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT03573128's enrollment target sits among peer trials
72 1089th of 2000 higher than 899 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02359253 · 72 participants · NA
Robot Aided Rehabilitation - Intervention
- NCT02962661 · 72 participants · Phase 1
Donor Bone Marrow Derived Mesenchymal Stem Cells in Controlling Heart Failure in Patients With Cardiomyopathy Caused by Anthracyclines
- NCT03113643 · 72 participants · Phase 1
SL-401 in Combination With Azacitidine or Azacitidine/Venetoclax in Acute Myeloid Leukemia (AML), High-Risk Myelodysplastic Syndrome (MDS) or Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN)
- NCT03187535 · 72 participants · NA
Effect of TEAS on PONV After Spinal Surgery
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI